|
1. Indications And Usage Montelukast Sodium Tablets Are A Leukotriene Receptor Antagonist Indicated For: • Prophylaxis And Chronic Treatment Of Asthma In Patients 2 Years Of Age And Older (1.1). • Acute Prevention Of Exercise-Induced Bronchoconstriction (Eib) In Patients 15 Years Of Age And Older (1.2). • Relief Of Symptoms Of Allergic Rhinitis (Ar): Seasonal Allergic Rhinitis (Sar) In Patients 2 Years Of Age And Older , And Perennial Allergic Rhinitis (Par) In Patients 2 Years Of Age And Older (1.3). 1.1 Asthma Montelukast Sodium Is Indicated For The Prophylaxis And Chronic Treatment Of Asthma In Adults And Pediatric Patients 2 Years Of Age And Older. 1.2 Exercise-Induced Bronchoconstriction Montelukast Sodium Is Indicated For Prevention Of Exercise-Induced Bronchoconstriction (Eib) In Patients 15 Years Of Age And Older. Pediatric Use Information For Patients Ages 6 To 14 Years Of Age For Acute Prevention Of Exercise-Induced Bronchoconstriction (Eib) Is Approved For Merck Sharp & Dohme Corp's Montelukast Tablet Products. However , Due To Merck Sharp & Dohme Corp's Marketing Exclusivity Rights , This Drug Product Is Not Labeled With That Pediatric Information. 1.3 Allergic Rhinitis Montelukast Sodium Is Indicated For The Relief Of Symptoms Of Seasonal Allergic Rhinitis In Patients 2 Years Of Age And Older And Perennial Allergic Rhinitis In Patients 2 Years Of Age And Older.
|